|
1
|
Moertel CG, Dockerty MB and Baggenstoss
AH: Multiple primary malignant neoplasms. II. Tumors of different
tissues or organs. Cancer. 14:231–237. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Billroth T: General surgical pathology and
therapeutics in 51 Vorlesungen: A textbook for students and
physicians in fifty-one lectures (14th). Berlin, DE: G. Rerimer.
1889.
|
|
3
|
Warren S and Gates O: Multiple primary
malignant tumors: Surgery of literature and statistical study. Am J
Cancer. 16:1358–1414. 1932.
|
|
4
|
Tsukuma H, Fujimoto I, Hanai A, Hiyama T,
Kitagawa T and Kinoshita N: Incidence of second primary cancers in
Osaka residents, Japan, with special reference to cumulative and
relative risks. Jpn J Cancer Res. 85:339–345. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Bray F, Center M, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rossi A, Chiodini P, Sun JM, O'Brien ME,
von Plessen C, Barata F, Park K, Popat S, Bergman B, Parente B, et
al: Six versus fewer planned cycles of first-line platinum-based
chemotherapy for non-small-cell lung cancer: A systematic review
and meta-analysis of individual patient data. Lancet Oncol.
15:1254–1262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thanendrarajan S, Nowak M, Abken H and
Schmidt-Wolf IG: Combining cytokine-induced killer cells with
vaccination in cancer immunotherapy: More than one plus one. Leuk
Res. 35:1136–1142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han RX, Liu X, Pan P, Jia YJ and Yu JC:
Effectiveness and safety of chemotherapy combined with dendritic
cells co-cultured with cytokine-induced killer cells in the
treatment of advanced non-small-cell lung cancer: A systematic
review and meta-analysis. PLoS One. 9:e1089582014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wray J, Morris CG, Kirwan JM, Amdur RJ,
Werning JW, Dziegielewski PT and Mendenhall WM: Radiation therapy
for nasal vestibule squamous cell carcinoma: A 40-year experience.
Eur Arch Otorhinolaryngol. 2015 Mar 13;(Epub ahead of print).
PubMed/NCBI
|
|
10
|
Jeannon JP, Riddle PJ, Irish J, O'sullivan
B, Brown DH and Gullane P: Prognostic indicators in carcinoma of
the nasal vestibule. Clin Otolaryngol. 32:19–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kummer E, Rasch CR, Keus RB, Tan IB and
Balm AJ: T stage as prognostic factor in irradiated localized
squamous cell carcinoma of the nasal vestibule. Head Neck.
24:268–273. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agger A, von Buchwald C, Madsen AR, Yde J,
Lesnikova I, Christensen CB, Foghsgaard S, Christensen TB, Hansen
HS, Larsen S, et al: Squamous cell carcinoma of the nasal vestibule
1993–2002: A nationwide retrospective study from DAHANCA. Head
Neck. 31:1593–1599. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wong CS, Cummings BJ, Elhakim T and Briant
TD: External irradiation for squamous cell carcinoma of the nasal
vestibule. Int J Radiat Oncol Biol Phys. 12:1943–1946. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Patel P, Tiwari R, Karim AB, Nauta JJ and
Snow GB: Squamous cell carcinoma of the nasal vestibule. J Laryngol
Otol. 106:332–336. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fornelli RA, Fedok FG, Wilson EP and
Rodman SM: Squamous cell carcinoma of the anterior nasal cavity: A
dual institution review. Otolaryngol Head Neck Surg. 123:207–210.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samaha M, Yoskovitch A, Hier MP and Black
MJ: Squamous cell carcinoma of the nasal vestibule. J Otolaryngol.
29:98–101. 2000.PubMed/NCBI
|
|
17
|
Dowley A, Hoskison E, Allibone R and Jones
NS: Squamous cell carcinoma of the nasal vestibule: A 20-year case
series and literature review. J Laryngol Otol. 122:1019–1023. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Quinn FB Jr and Mccabe BF: Laryngeal
metastases from malignant tumors in distant organs. Ann Otol Rhinol
Laryngol. 66:139–143. 1957.PubMed/NCBI
|
|
19
|
Oien KA: Pathologic evaluation of unknown
primary cancer. Semin Oncol. 36:8–37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang YC, Chang PM, Lee IC, Yang CF, Tzeng
CH and Yang MH: Duodenal squamous cell carcinoma derived from the
hypopharynx: Immunohistochemical assessment of metastatic
mechanisms. Gastrointest Endosc. 72:460–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tabuchi T, Ito Y, Ioka A, Miyashiro I and
Tsukuma H: Incidence of metachronous second primary cancers in
Osaka, Japan: Update of analyses using population-based cancer
registry data. Cancer Sci. 103:1111–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Youlden DR and Baade PD: The relative risk
of second primary cancers in Queensland, Australia: A retrospective
cohort study. BMC Cancer. 11:832011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Freeman HJ: Triple metachronous colon
cancer. World J Gastroenterol. 19:4443–4444. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rosso S, De Angelis R, Ciccolallo L,
Carrani E, Soerjomataram I, Grande E, Zigon G and Brenner H:
EUROCARE Working Group: Multiple tumours in survival estimates. Eur
J Cancer. 45:1080–1094. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Utada M, Ohno Y, Hori M and Soda M:
Incidence of multiple primary cancers and interval between first
and second primary cancers. Cancer Sci. 105:890–896. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Filali K, Hédelin G, Schaffer P, Estève J,
Arveux P, Bouchardy C, Exbrayat C, Faivre J, Lévi F, Macé-Lesech J,
et al: Multiple primary cancers and estimation of the incidence
rates and trends. Eur J Cancer. 32A:683–690. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Crocetti E, Buiatti E and Falini P:
Italian Multiple Primary Cancer Working Group: Multiple primary
cancer incidence in Italy. Eur J Cancer. 37:2449–2456. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Curtis RE, Boice JD Jr, Kleinerman RA,
Flannery JT and Fraumeni JF Jr: Summary: Multiple primary cancers
in Connecticut 1935–82. Natl Cancer Inst Monogr. 68:219–242.
1985.PubMed/NCBI
|
|
29
|
Ikeda Y, Tsukuda M, Ishitoya J, Arai Y,
Matsuda H, Katori H, Taguchi T, Yoshida T, Ono M, Sakuma Y, et al:
Four cases of simultaneous triple primary cancers of the
hypopharynx, esophagus and stomach. Otolaryngol Head Neck Surg.
132:788–793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Travis LB, Rabkin CS, Brown LM, Allan JM,
Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele
A, et al: Cancer survivorship - genetic susceptibility and second
primary cancers: Research strategies and recommendations. J Natl
Cancer Inst. 98:15–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Travis LB: The epidemiology of second
primary cancers. Cancer Epidemiol Biomarkers Prev. 15:2020–2067.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuligina E, Reiner A, Imyanitov EN and
Begg CB: Evaluating cancer epidemiologic risk factors using
multiple primary malignancies. Epidemiology. 21:366–372. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiao F, Hu H and Wang LW: Quadruple
primary malignancy patient with survival time more than 20 years.
World J Gastroenterol. 19:1498–1501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adami HO, Hunter D and Trichopoulos D:
Textbook of cancer epidemiology (2nd). Oxford University Press. New
York: 2002.
|
|
35
|
Hiyama T, Sato T, Yoshino K, Tsukuma H,
Hanai A and Fujimoto I: Second primary cancer following laryngeal
cancer with special reference to smoking habits. Jpn J Cancer Res.
83:334–339. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Botteri E, Iodice S, Bagnardi V, Raimondi
S, Lowenfels AB and Maisonneuve P: Smoking and colorectal cancer: A
meta-analysis. JAMA. 300:2765–2778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
DeVita VT Jr and Rosenberg SA: Two hundred
years of cancer research. N Engl J Med. 366:2207–2214. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vital D, Morand G, Huber GF, Studer G and
Holzmann D: Outcome in squamous cell carcinoma of the nasal
vestibule: A single center experience. Head Neck. 37:46–51. 2015.
View Article : Google Scholar : PubMed/NCBI
|
